PRFX - Bathi resik saben saham (EPS TTM) PainReform Ltd
PainReform Ltd. delegates production and testing to external contractors, creating a strong dependency on vendors. Net income per share over the last four quarters helps identify the real business trend, where the value of -5.29 shows the most recent figure. Investors are awaiting approval of the PRF-110 gel, relying on FDA support. The company's goal is to replace opioids with safe methods of prolonged pain relief.
Rincian metrik komprehensif lan analitis PainReform Ltd (PRFX)
- rega saham lan prakiraan rega para ahli:
- statistik kapitalisasi pasar:
- rincian valuasi buku bisnis:
- statistik kawajiban utang lan likuiditas:
Utang marang Ekuitas PainReform Ltd.|PRFX - Kewajiban jangka dawa marang ekuitas|Utang jangka cendhak marang modal PainReform Limited|PRFX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku PainReform Ltd.|PRFX - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan PainReform|Likuiditas cepet painreform.com
- indikator pendapatan resik lan kelipatan nilai:
PRFX - Bathi pungkasan|Proyeksi bathi mangsa ngarep PainReform Ltd.|PRFX - Kapitalisasi marang bathi|Pangali Forward P/E PainReform|PRFX - Rasio kapitalisasi marang bathi lan wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan PainReform Ltd.|PRFX - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan PainReform|PRFX - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan painreform.com|PRFX - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep PainReform Ltd.
Analisis kabeh metrik perusahaan:PainReform Ltd. (PRFX)
This metric is calculated as the ratio of total annual net income to the number of shares outstanding. The metric determines the actual earnings per share, neutralizing the impact of issuance. For PainReform Ltd. (PRFX), this calculation is critical when competing with behemoths in the hospital segment. Profit growth confirms the effectiveness of niche analgesic drugs. By analyzing the company's EPS TTM dynamics, an investor assesses the fundamental resilience of the business to market pressure.
Pesaing PainReform Ltd.
HLN: Bathi resik saben saham sajrone 12 wulan pungkasan|kenvue.com - Bathi saben saham sajrone patang kuartal pungkasan|VRNA: Bathi resik saben saham (EPS TTM)|Jyong Biotech Limited - Bathi saben saham sajroning taun lumaku|LGND (Ligand Pharma) - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan Amneal Corp AMRX|Bathi saben saham sajrone rolas wulan pungkasan Perrigo Company plc (PRGO)|ALVO (alvotech.com) - Bathi saben saham sajroning taun lumaku|Bathi saben saham sajrone rolas wulan pungkasan Liquidia LQDA|GLPG (Galapagos N.V.) - Bathi saben siji saham sajrone 12 wulan pungkasan|ANI Pharma - Bathi resik saben saham (EPS TTM)|MNKD - Bathi resik saben saham (EPS TTM)|AMPH: Bathi resik saben saham (EPS TTM)|PCRX - Bathi resik saben saham sajrone patang kuartal pungkasan|Bathi saben saham sajrone rolas wulan pungkasan ARS Pharmaceuticals, Inc.|Bathi saben saham sajrone 12 wulan pungkasan TBPH (Theravance Biopharma Inc)|Bathi saben saham sajrone rolas wulan pungkasan Aquestive Pharma (AQST)|SCPH (scpharmaceuticals.com) - Bathi saben saham sajroning taun lumaku|Bathi resik saben saham (EPS TTM) TECX (Tectonic Therapeutic)|tonixpharma.com (TNXP) - Bathi resik saben siji saham sajrone rolas wulan pungkasan|SXT China - Bathi resik saben saham (EPS TTM)|Bathi saben siji saham sajrone 12 wulan pungkasan EPRX|BioHarvest (BHST) - Bathi saben saham sajrone rolas wulan pungkasan|Bathi resik saben siji saham sajrone rolas wulan pungkasan Invizyne (EXOZ)|Bathi saben saham sajrone rolas wulan pungkasan Oramed|ENTX: Bathi saben saham sajroning taun lumaku|Bathi saben saham sajrone rolas wulan pungkasan MindWalk Holdings Inc. (HYFT)|Bathi resik saben saham sajrone 12 wulan pungkasan ABVC BioPharma Inc. ABVC|Cumberland Pharma - Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi saben saham sajroning taun lumaku QNTM|FGEN - Bathi saben saham sajrone rolas wulan pungkasan|TELO: Bathi saben saham sajrone rolas wulan pungkasan|RANI (ranitherapeutics.com) - Bathi resik saben saham sajrone 12 wulan pungkasan|SNYR: Bathi saben saham sajrone patang kuartal pungkasan|RLYB (Rallybio Corp) - Bathi resik saben saham (EPS TTM)|Bathi saben saham sajrone 12 wulan pungkasan LEXX (Lexaria)|Bathi resik saben saham sajrone 12 wulan pungkasan PULM (Pulmatrix, Inc.)|Bathi resik saben saham sajrone patang kuartal pungkasan ftzy.com.cn|Bathi saben saham sajrone rolas wulan pungkasan Aptorum Group APM|LYRA (Lyra Therapeutics Inc.) - Bathi saben siji saham sajrone 12 wulan pungkasan|IBO - Bathi saben saham sajrone rolas wulan pungkasan|Bathi saben saham sajroning taun lumaku TNFA (TNF Pharmaceuticals)|YCBD: Bathi resik saben saham (EPS TTM)|Bathi saben siji saham sajrone 12 wulan pungkasan CYTO (Altamira Therapeutics Ltd.)|Bathi resik saben saham sajrone 12 wulan pungkasan LIPO|Bathi saben saham sajrone 12 wulan pungkasan OPTN (OptiNose Inc)|Bathi saben saham sajrone rolas wulan pungkasan Pieris (PIRS)|PROC: Bathi saben siji saham sajrone 12 wulan pungkasan|Bathi resik saben saham (EPS TTM) PTPI (Petros Pharmaceuticals)|Bathi saben saham sajroning taun lumaku QLI|ACELYRIN - Bathi resik saben saham (EPS TTM)|TFFP - Bathi resik saben saham (EPS TTM)
